HeartSciences (HSCS) Cost of Revenue (2021 - 2025)

HeartSciences' (HSCS) quarterly Cost of Revenue came in at $1008.0 in Q4 2025, up 32.63% on a QoQ basis from $760.0 in Q3 2025.

HeartSciences (HSCS) Cost of Revenue (2021 - 2025) Analysis & Trends

HeartSciences (HSCS) has 5 years of Cost of Revenue data on file, last reported at $1008.0 in Q4 2025.

Quarterly Cost of Revenue changed N/A year-over-year to $1008.0 in Q4 2025, while the trailing twelve-month figure through Apr 2026 was $3648.0 (down 43.36% YoY) and the FY2026 annual result came in at $1768.0, down 5.96% from the prior year.
Cost of Revenue advanced to $1008.0 in Q4 2025, from $760.0 in the prior quarter.
In the past five years, Cost of Revenue ranged from a high of $5756.0 in Q3 2021 to a low of $760.0 in Q1 2023.
A 5-year average of $2041.5 and a median of $1400.0 in 2022 frame the typical range for Cost of Revenue.
Annual changes were most pronounced in 2022 — Cost of Revenue tumbled 64.63% — and 2024, when it jumped 500.13%.
Tracing HSCS's Cost of Revenue over 5 years: stood at $5756.0 in 2021, then plunged by 64.63% to $2036.0 in 2022, then slipped by 25.34% to $1520.0 in 2023, then soared by 200.07% to $4561.0 in 2024, then tumbled by 77.9% to $1008.0 in 2025.
The last three Cost of Revenue figures came in at $1008.0 (Q4 2025), $760.0 (Q3 2025), and $1880.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Abbott Laboratories	200.50 Bn	194.89 Bn	7.27 Bn	5.33 Bn
2	Stryker	130.00 Bn	126.52 Bn	4.50 Bn	2.09 Bn
3	Medtronic	120.36 Bn	111.14 Bn	6.41 Bn	3.40 Bn
4	Boston Scientific	74.19 Bn	73.65 Bn	3.85 Bn	1.59 Bn
5	Edwards Lifesciences	52.73 Bn	48.48 Bn	1.35 Bn	392.40 Mn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn	478.40 Mn
7	GE HealthCare Technologies	34.13 Bn	32.02 Bn	2.18 Bn	2.25 Bn
8	Koninklijke Philips	26.52 Bn	23.20 Bn	4.55 Bn	2.57 Bn
9	Steris	23.23 Bn	22.75 Bn	684.20 Mn	808.60 Mn
10	HeartSciences	6.75 Mn	5.05 Mn	-	-

Download Data